Clarity On Rona Ambrose

Ed Tanas helps shed some light on the temporary Tory leader and chief resident hypocrite (competing with Tony Clement for that title, of course).

On The Dyspeptic Rona Ambrose

In a post last week, I explained the basis for my outrage over Health Minister Rona Ambrose's manufactured rant at the Supreme Court's decision permitting medical marijuana users to ingest their medicine in any form they wish. Reading this morning's Star letters to the editor, I was pleased to see that I am not alone in my reaction to Ms Ambrose and the regime she is a mouthpiece for.

Here are but a few of many excellent missives:

Re: Chill out, minister, Editorial June 14

How ironic is this? Rona Ambrose, health minister in the Harper government, infamous for their disdain for science, invokes science in her rejection of the Supreme Court decision on medical marijuana.

While I happen to agree that much of the medical use of marijuana is not evidence based, the Harper government shows their cynicism in challenging medical marijuana. It’s not a good fit with their popular tough-on-crime agenda, which the evidence shows is expensive, ineffective and cruel.

When this government revitalizes StatsCan, environmental research and protection and evidence based justice then they can legitimately pronounce on marijuana use.

Peter Crosby, Toronto

Kudos to the Supreme Court for legalizing the use of medical marijuana through oils and foods; it is a common-sense decision that will benefit patients across Canada, and have a profound effect on the lives of individuals with the most extreme forms of epilepsy.

For years, too many of our members have been unable to control their seizures with conventional therapies. Medical marijuana has provided seizure control for adults and children, some of whom have gone from having dozens of seizures every day to none. While more research is needed, these anecdotal cases are having a real impact on the lives of many people with epilepsy.

Providing families with the option to use oils and foods to take their medical marijuana instead of being forced to smoke or inhale it gives individuals already living with medical challenges an easier and more sensible way of getting the medication they need.

Drew Woodley, Director of Communications, Epilepsy Toronto

Perhaps Health Minister Rona Ambrose’s sense of outrage about the Supreme Court decision regarding medical marijuana could have been better directed at her boss. If she had done her homework she would have discovered that the Harper government itself cancelled the research component of the medical marijuana program shortly after he took office.

Since he wasn’t able to obliterate the program entirely he quickly began the process of enacting barriers and demonizing users. Ironically if he had known then that he would later learn to muzzle scientific communications at will, he could have let the research go on, comfortable that any unwanted positive findings would never be heard.

It is so like this government to be so easily outraged when frustrated, much like a toddler.

Steven Gaber, Toronto

Health Minister Rona Ambrose is “outraged” that the Supreme Court ruled unanimously that marijuana can be legally consumed in forms other than smoking. “This is not a drug,” she said. “This is not medicine.”

Such breathtakingly ill-informed statements coming out of the mouth of a so-called health minister is appalling. I wonder if she would be willing to repeat such canards to all of the children with debilitating forms of epilepsy who are helped through the ingestion of small amounts of various cannabis preparations? Perhaps she could embrace one of these children in her motherly arms as they suffer yet another seizure, maybe offer them a joint?

Strains of low or no THC marijuana that are high in cannabidiol (CBD) have been developed and have proven remarkably effective at controlling not only seizures, but providing relief from neuropathic pain, PTSD, Crohn’s disease, and nausea as a result of chemotherapy, to name but a few. The loving minister, however, appears to be wantonly ignorant of such developments to the point of unmitigated callousness.

Ambrose goes on to say “There’s very harmful effects of marijuana, especially on our youth.” Really? Would the good madame care to list them?

I applaud the Supreme Court and the wisdom of its decision. If only such sage reasoning could be instilled elsewhere, beginning with the health minister’s office.

Walter Ross, West Richland, Wash.

UPDATED: I'm Outraged Over Her Outrage

Playing to her party's base, Health Minister Rona Ambrose yesterday expressed "outrage" over the Supreme Court's unanimous decision to make it legal for medical marijuana users to ingest their pot in any manner they see fit, be it oils, tinctures, cookies, or brownies. Given her well-demonstrated ineptitude in ensuring that Health Canada protect the health of Canadians, (apparently preferring to protect the health of pharmaceuticals' profits), something about which I have written at length on this blog, the integrity of yesterday's partisan denunciation of the court's decision must surely be called into question:



In the interests, as they say, of full disclosure, I do have a personal interest in this subject. My wife, for the past few years, suffered intractable and debilitating pain, pain that was relieved neither by over-the-counter medications nor narcotic painkillers. Happily, after recent surgery, most of that pain should be a thing of the past. Her suffering, however, was a disillusioning revelation to both of us; we had always assumed that most pain could be managed as long as doctors were willing to prescribe the necessary amounts of medication. This is not the case.

While I cannot say for certain that medical pot would have provided the sought-after relief, (and truth be told, my wife did not ask her doctor if he would prescribe it), I became resentful over two things: the fact that her access to it would have depended upon her doctor's beliefs and values, and the fact that Health Canada forbade the ingestion of medical pot in all forms except its dried form, which must be smoked or vaporized. Owing to a lung condition that she has, my wife would thus have been unable to use it in that form. Until yesterday's ruling, she would have been deemed a criminal.

Rona Ambrose asserts that research needs to be done to back up anecdotal claims of pot's medicinal benefits. She is surely being disingenuous here, given that big pharma will not undertake costly research into a substance that they cannot patent, and U.S,. medical research is severely circumscribed due to cannabis being listing as a Schedule 1 drug, reserved for the most dangerous of substances, right up there with heroin. Legal access is therefore difficult to obtain. Fortunately, in some parts of the world, enlighted attitudes coupled with compassion mean research is ramping up.

Beyond its benefits for pain relief, there are many claims to its benefits in treating intractable epilepsy:



And some in the medical community are quite receptive to the possibilities. Click here to play the clip.


If you want to read more about the above program and one mother's tireless battle to legally bring in a tincture from Colorado to her home state of Virginia to treat her saughter, click here. or watch the full program upon which the above is excerpted here. I watched the program when it aired, a good piece of journalism that one would have to be pretty hard-hearted not to be moved by.

Rona Ambose's obduracy of spirit, evidenced in her denunciation of the Supreme Court decision, is unacceptable and a gross insult to all who seek wider access to a medicine that may help them. The Harper regime's shameful trumping of ideology over compassion has no place in the Canada I know and live.

UPDATE: Even if you lack the time or the inclination to watch the Dateline program I described above, go to the 28 minute mark where you will see a vet suffering from PTSD who moved to Coloradeo to have access to marijuana. He displays all of the medications he was prescribed, which he says made him feel like a zombie, that he was able to dispose of once he started using cannabis to treat his condition. It is a powerful visual of what is at stake for the pharmaceuticals and suggests why they are likely a powerful force against widening marijuana's use.

Health Canada Fails Us Yet Again

On this blog I have frequently extolled the fine investigative journalism practised by The Toronto Star. Whether on issues of municipal, provincial, or federal significance, The Star, as it frequently proclaims, "gets action."

From the standpoint of average Canadians, probably one of its most important investigations in recent times has been into Health Canada and its all too cozy relationship with the pharmaceutical industry, an industry protectorate seems to treat more as an equal than as an activity to be regulated. its relationship with the generic company Apotex is especially troubling.

Despite previous avowals by Health Minister Rona Ambrose that things would improve, it seems that business as usual prevails at Apotex. Yesterday, The Star reported that problems have again been uncovered, this time at its Brantford palant, information that, as in the past, comes not from Health Canada, but the U.S. Food and Drug Administration:

At the Brantford facility in November, FDA inspectors found the company launched an internal review in 2013 to ensure it was effectively cleaning the equipment used to make drug products. Three swab tests of the equipment found unacceptable levels of contamination.

But Apotex shelved its internal review “until (an) effective cleaning procedure is developed,” according to an Apotex memo reviewed by FDA inspectors.

Then, in September 2014, the company made multiple batches “using the same equipment cleaning methods that failed the cleaning validation,” FDA inspectors found.

The company then released the drug products “based on a less stringent” quality-control requirement.

What were the possible contaminants?

An industry expert said the most common contamination from improperly cleaned equipment would be bacteria or trace amounts of another drug or antibiotic made using the same machines.

So where was Health Canada in all of this?

The agency, which had conducted its own inspection in July with similar discoveries, tagged along with the FDA in its November inspection. But that's where common ground diverges. While the FDA made the result of the inspection publicly available, Health Canada says it is still finalizing the report from its July inspection.

A hard-hitting editorial in today's Star makes it abundantly clear that this kind of cavalier foot-dragging is unacceptable:

That’s not good enough. It’s January and drugs that could possibly be contaminated are on the market.

Health Canada must move a lot more quickly to ensure consumer safety. And it clearly needs to take a much more rigorous look into Apotex’s manufacturing practices. The company has a long history of safety issues at its plants.

The editorial ends with sentiments that few Canadians could disagree with:

In the end, consumers are dependent on Health Canada — not the FDA — to ensure that drugs on the Canadian market are safe and effective. Health Canada should immediately identify the drugs in question and issue its report on Apotex’s Brantford plant. And it needs to have a good hard look at all of Apotex’s manufacturing practices.

Consumer safety is at stake.

That, strangely enough, does not seem to be a priority with Health Canada.

It's Why I Subscribe

To borrow a line from one of my favourite Shakespearean plays, Macbeth, "So fair and foul a day I have not seen."

It is fair because the newspaper I subscribe to and heartily endorse, The Toronto Star, has achieved a victory whose significance cannot be overestimated. Thanks to its investigative series into Health Canada's scandalous and potentially life-threatening negligence in overseeing drug safety, Health Minister Rona Ambrose, has finally acted:

Health Canada has banned the import of all drugs and drug ingredients made by two Apotex factories in Bangalore, India, with Health Minister Rona Ambrose saying Tuesday night that the trust between the regulator and the Toronto-based drug company has been “broken.”

Despite that action, long in coming, there are no plans to recall any of the 30 suspect drugs manufactured at the plants, drugs that include

a generic form of Viagra, the antibiotic azithromycin, and other drugs made to treat hypertension, dementia, high blood pressure, asthma, convulsions and Lou Gehrig’s disease.

Not surprisingly, the information that led to the decision was taken from the FDA database, which is fully transparent and accessible to the public.

So what is foul? Two things:

One, had it not been for the tenacity of The Star, Health Canada would have continued to give its imprimatur to potentially life-threatening drugs, thereby egregiously failing in one of the most important aspects of its mission.

Two, despite the significance of the scandal, and despite the fact that it provoked some intense questioning from the NDP in The House of Commons, no other media outlets reported the story to my knowledge, not even the CBC, our putative national broadcaster.

Why the silence? One can only speculate, but I do intend very soon to write a letter to the CBC to ascertain the reason. Some might link it to the Corporation's policy of appeasement, about which I have written previously.

I will let you know if I get any response from the CBC.

A Possible Soution To Health Canada's Willful Impotence

Yesterday I wrote about the fact that Health Canada has 'convinced' (not ordered) Apotex to stop importing drugs from one of its suspect plants in Bangalore, India. The agency's (and Health Minister Rona Ambrose's) ongoing timid relationship with pharmaceuticals at the expense of our health and safety suggests stronger measures are needed

Writing in The Star, Amir Attaran thinks he might have a solution to this sorry state of affairs. The professor in the Faculty of Law and faculty of Medicine at the University of Ottawa asks,

should we reduce, or nearly abolish, Health Canada’s drug regulatory functions? Could we be safer by trusting in the decisions of larger, better-funded, foreign drug regulators instead of little lame Health Canada?

He looks to Europe for a model:

The 28 countries of the European Union, many of them quite small, long ago decided that it is expensive, inefficient and sometimes dangerously ineffective for each country to have its own drug regulator. Nowadays, most of them have delegated large parts of their drug regulatory functions to an EU-wide organization, the European Medicines Agency.

Attaran is not optimistic that Canada will likely follow suit with a similar co-operative venture:

Here, the Harper government’s asphyxiating control of government scientists and almost childish pride in Canadian sovereignty mean that Health Canada minimally co-operates with America’s FDA just next door. This is dumb: the FDA is more transparent, better resourced and scientifically better equipped than Health Canada will ever be.

He goes on to offer a picture of the FDA's ruthless effectiveness in interdicting suspect drugs:

Consider the case of Ranbaxy, a pharmaceutical company from India. Last year, the FDA successfully prosecuted Ranbaxy for manufacturing adulterated drugs and misleading it with false, fictitious and fraudulent drug testing data — crimes for which Ranbaxy paid $500 million (U.S.) in criminal and civil penalties.

Contrast that decisiveness with Health Canada's feckless dealings with the same company:

Even though former Ranbaxy executives say they are “confident there were problems” with drugs sold here, after the criminal conviction Health Canada refused to ban Ranbaxy’s factories, and instead negotiated with the company to voluntarily pull a few of its medicines off the market for testing; Health Canada won’t say which ones.

According to Attaran, the main reason for this gross disparity of response is not legal, but cultural,

namely the indolent, lapdog attitude of ministers like Ambrose and the public servants at Health Canada, who seem to lack any understanding of how governments should regulate.

Because they refuse to learn from the best practices of bodies like the FDA and the European Medicines Agency, he concludes that

we should in part abolish Health Canada and harmonize our drug regulation with those foreign agencies that are more competent than our own government.

While that might strike many as too drastic a solution, it is clear that major changes are needed if we are to be protected from corrupt and venal pharmaceutical companies that place their profits and their shareholders above the health and safety of Canadians.

Health Canada's Willful Impotence on Tainted Pharmaceuticals

As I have written previously, the scandal of tainted pharmaceuticals continues, and that which should provoke outrage and demands for accountability seems to elicit for the most part only shrugs and mild interest. And were it not for the Toronto Star's ongoing quest, most of us would be totally unaware of the threats to our health that are aided and abetted by Health Canada and Health Minister Rona Ambrose, thanks to a larger media, including the CBC, that have given the scandal absolutely no coverage.

Despite the investigative series conducted by the paper and an excoriating editorial, the only action thus far taken by Health Minister Rona Ambrose and her recalcitrant department has been to 'convince' (not order) Apotex to

stop distribution to Canadian retailers of what Health Minister Rona Ambrose described as “all products” manufactured at one of Apotex’s factories in Bangalore, India.

“The quarantine will allow the department time to verify that products from this facility meet Canadian safety and quality requirements,” Health Canada said in a short release.

I guess that is progress of sorts, since the last time Health Canada made such a request, Apotex refused. However, it is an anemic response given that when the issue first arose, the FDA banned the suspect drugs from entering the U.S.

However, even in Health Canada's putative victory with Apotex, there is less here than meets the eye, as is typical of the Harper regime:

Health Canada has not told the public what drugs are affected by this quarantine.

So even though many Canadians will have been taking these suspect and tainted drugs, they are not permitted to know which ones they are. Undoubtedly, as has been previously discussed, in the warped of Ambrose and her department, that information is considered commercially confidential.

In my next post, I'll discuss a possible way around the protective wall of silence erected by Health Canada to protect the pharmaceutical industry.

Star Readers Respond To Health Canada's Fecklessness

While "Let them swallow tainted pharmaceuticals" seems to be the motto of both Health Minister Rona Ambrose and Health Canada, always-vigilant Star readers take issue with such deference to the corporate agenda. Here is just a small sampling of their reactions:

Good thing we have the FDA and the Star to look after our best interests with regards to clinical drug trials. Health Canada appears to just run diversion tactics for the medical profession and big pharma.

Richard Kadziewicz, Scarborough

I really appreciate all of the hard work that David Bruser and Jesse McLean are doing to enlighten and inform us about the irresponsible practices of Health Canada. I’m sure it has been next to impossible to obtain salient information from the government organization that is in place to supposedly protect its citizens but instead have to rely on the FDA.

It begs the question as to why. Are they under-staffed or are they protecting the corporations known as Big Pharma? Like the majority of Canadians I resent and abhor that the products we consume are being produced offshore with apparently little or no quality control. At our peril, the corporations’ only consideration is profit. The eroding job market and our health is of little consequence when their insatiable greed is paramount. It’s obscene.

As a citizen, I don’t know how we fight for accountability. Health Canada exists because of our taxes, this practice is unacceptable. Or are the corporations really the body governing our country?

Vivien C. Buckley, Burlington

Looking at the failure of Health Canada to inform Canadians of the shortcomings of part of our pharmaceutical industry, one comes to two conclusions about Health Canada: it was putting the health of Canadians at risk; and it might as well not have done their regulatory work at all. Exactly the same might be said of the Canadian government agency in charge of inspecting meat processing plants.

How about the work of government scientists studying forestry, fisheries, climate, water quality, economics, environment, national statistics, etc? The Harper government appears to have suggested that their work was solely to inform cabinet decisions. If so, that may explain why the “Harpies” do not allow government scientists to speak publicly about their work.

From my point of view, the tax-cutting Tories would be well advised to close all our scientific establishments. Since they largely ignore the scientific work available to them, and will not let the public see the results either, why do it at all?

Clearly, one should never let the facts trump a good ideology.

Peter Bursztyn, Barrie

The Star has informed its readers of the incompetence by Health Canada in keeping the results of their investigations into pharmaceutical companies a secret from the taxpayers they work for.

Health Canada has become another whore in the Harper government, playing along with again a secret policy of giving information to the public only if it is of benefit to federal government.
......

When the next Prime Minister replaces this dictatorship after the next election, I hope that he would fire every single manager at Health Canada, no matter what the management rank is, and replace them with contractors hired from the FDA. It seems that only then will we get what we are paying for.

Robert Knight, Toronto

As well, the Star has an editorial in today's issue that offers a good overview of this scandalous issue.

Tainted Pharmaceuticals: Health Canada's 'Feeble Response'

The Toronto Star has recently been conducting some fine investigative work on tainted pharmaceuticals and the fact that Health Canada has been shielding the guilty companies from public scrutiny. The issue finally rose to a degree of national prominence this week when the issue was raised in the House. The 'answers' provided by Health Minister Rona Ambrose, however, were hardly comforting or reassuring. The bolded parts have been added for emphasis:

“Whenever there is a dangerous product identified, Health Canada inspectors act immediately. In the case of a drug produced by Apotex, Health Canada inspectors asked the company to remove it from the shelf and it refused,” Ambrose said in question period this week in response to questions spurred by a recent Star investigation.

This somehow reminds me of the boy with the sign on his back that says, Kick Me.

In fact, the Canadian government, unable to force the company to recall the drug, twice asked Apotex to “stop sale and cease imports” from the Bangalore facility, Health Canada spokesman Gary Holub said in response to further questions from the Star.

Apparently a believer in the old adage that you can catch more flies (an apt metaphor in this case, given the filthy conditions of Apotex's Bangalore plant) with honey than vinegar, our national health protector changed tacks:

“Although Apotex refused Health Canada’s initial request, it was determined that a more productive course would be to work with the company to quickly determine steps to ensure the safety of its products, over engaging in lengthy court proceedings with no immediate mitigation measures,” Holub said in an email.

Amir Attaran, a University of Ottawa law professor who researches drug policy, called Health Canada’s response “feeble, inadequate and incompetent.”

In the house, Ambrose claimed that she needs stronger legislation to act definitively and decisively against the offending companies:

“It will require tough new fines for companies that are putting Canadians at risk. Most importantly, it will give me the authority to recall unsafe drugs when I need to,”

This claim of legislative impotence surely rings hollow, and does not explain the fact that Health Canada refuses to publish the names of companies contravening drug safety practices nor the names of the offending drugs.

Professor Attaran succinctly sums up the real problem: “This proves Health Canada is on the side of drug companies and not Canadians”.

I have nothing to add to his assessment.

More Indifference From Health Canada's Towards Canadians' Health

Health Minister Rona Ambrose really has no reason to smile.

Last week, based on a Star Investigation, I outlined the shocking incompetence, indifference and completely unacceptable secrecy within Health Canada that allows for tainted, ineffective, and dangerous drugs to be sold regularly to Canadians. It was only because of the transparency of the American Federal Drug Administration that The Star was able to uncover this wholly unacceptable and outrageous state of affairs.

Unfortunately, the story doesn't end there.

Continuing its investigation, The Star has uncovered, thanks to the FDA database and freedom of information requests that were answered fully and expeditiously by that body, more shocking failures on the part of Health Canada. This one involves clinical trials. Fraud, incompetence and corruption do not seem overly strong terms to describe what they have uncovered:

In 2012, a top Toronto cancer researcher failed to report a respiratory tract infection, severe vomiting and other adverse events.

A clinical trial run by an Alberta doctor reported that patients responded more favourably to the treatment than they actually did.

A Toronto hospital’s chief of medical staff ran a clinical trial of autistic children on a powerful antipsychotic, and he did not report side-effects suffered by four of the children.

The problems uncovered with clinical trial oversight seem to stem from the same factors that allow for tainted and ineffective formulations on the market: inadequate inspections by Health Canada (only a handful of the 4000 clinical trials running at any one time) and the latter's insistence on keeping the problems it covers secret, citing 'proprietary concerns.'

One cannot overestimate the importance of clinical trials: They

are experiments using volunteer subjects to determine whether a drug is safe and effective, as well as what side-effects it may cause. Participants may experience side-effects, which the doctors leading the trials must report.

Unfortunately, such protocols are being circumvented by Canadian doctors. Take the case of Dr. Sunil Verma, who chairs the breast medical oncology unit at Sunnybrook’s Odette Cancer Centre. An FDA inspection uncovered the fact that he failed to report to the sponsoring drug company adverse reactions suffered by five patients, including a respiratory tract infection and severe vomiting that lasted two weeks.

His explanation: “This was purely a clerical issue. This was clearly an oversight on the part of the nurse” .

Interestingly, Dr. Verma is on the drug company's advisory board, which pays him about $1500 each time he gives an “educational presentation” on breast cancer.

Overlapping, or what some might describe as incestuous, relationships between doctors and drug companies do not seem uncommon:

At the University of Calgary, Dr. Remo Panaccione’s has received money for consulting and lecturing from at least 26 different pharmaceutical companies.

Dr. Panaccione conducts research into inflammatory bowel disease. A clinical trial he led in 2007 into a drug designed to treat Crohn's disease was found deficient by an FDA inspection. He failed to report the hospitalization of three patients being treated to the university's ethics board. Like the aforementioned Dr. Verma, Panaccione blamed his staff for the “oversight.”

Then there is the case of Dr. Alexander Paterson, a renowned Alberta researcher, who has the dubious distinction

of being cited for violations in three FDA inspection reports — in 1988, 2002 and 2004 — more than any other Canadian doctor, according to a Star analysis of available FDA data.

During the first inspection, the FDA inspector uncovered a series of problems with the trial, including one the FDA said was “extremely” concerning: Patient information submitted by the pharmaceutical company to the FDA (to get the drug tamoxifen approved to treat cancer) did not match medical records found in Paterson’s possession.

In several cases, the copies given to the regulator suggested the treatment worked better than the doctor’s own progress notes indicated.

The inspection also found “possibly ineligible patients being enrolled in the study . . . and patients being incorrectly dosed.”

In one case, the inspector’s report says, the record submitted by the drug company said the patient’s response to the treatment involved “no change.” This was in direct conflict with the doctor’s record, which “lists the patient’s response as ‘worse.’ ”

Like the two previously mentioned doctors, Paterson had an explanation, blaming the findings on overzealous and out-of-their-depth FDA inspectors.

Errors, I am sure, happen all the time. After all, we are all human. But for me, the most important aspect of this story again is the fact that were it not for the openness and accessibility of FDA data, Canadians would be completely in the dark about these mistakes and coverups, all of which seem invariably to work to the benefit of the drug companies for which the researchers are doing their work. Health Canada seems completely unconcerned.

There is much more in the Star investigation, including a sole study by Hamilton doctors whose tainted data and failure to report serious side effects led to the approval of a drug thinner implicated in stroke, heart attacks and major hemorrhages. I hope you will read the entire report on the Star's website.

I will close with just one more excerpt from the Star investigation that speaks volumes about its indiifference to the health of Canadians:

Over the past 12 years, Health Canada found at least 33 clinical trials had critical problems and were “non-compliant.” In July, the Star asked for details of these and other inspections, and last week Health Canada refused, saying that providing records “would require an exhaustive manual paper file review.”

The regulator also said the release of these clinical trial inspection reports could only come after consultation with third parties, typically the doctors and drug companies.

In a country that prides itself on its medical system, this cannot be deemed acceptable by anyone.

Denial And Outrage

During my teaching career, it was occasionally my unpleasant task to confront a student with evidence of his or her cheating; most situations revolved around plagiarizing essays or having skipped a test. The student's responses when confronted were invariably the same; indeed, they tended to parallel Elizabeth Kubler-Ross' five stages of grief.

I won't bore you with the details, but common initial reactions were denial that any offence had occurred, ("I have no idea what you are talking about"), and when that failed, anger that I would harbour such unfounded and unworthy suspicions ("I am really hurt that you would accuse me of such a thing"). Invariably, they were guilty as charged.

There seems to be an analogous system at work in politics.

Let's start with the Harper regime's upcoming campaign against marijuana use, the one that the three main groups representing doctors, Family Physicians of Canada (CFPC), Canadian Medical Association (CMA) and the Royal College of Physicians and Surgeons of Canada have refused to be part of because they "... do not, support or endorse any political messaging or political advertising on this issue".

The accusation that the campaign has become a political football aimed at discrediting Justin Trudeau, who favours legalization of pot, has been hotly denied by Health Minister Rona Ambrose:

“Telling kids to not smoke pot is not a partisan attack on Justin Trudeau by Health Canada,” Ambrose told a news conference Monday on the sidelines of the annual Canadian Medical Association meeting.

“It is a sound public health policy backed by science. Whether pot is legal or illegal, the health risks of marijuana to youth remain the same, and we should all be concerned about them.”

She added that Trudeau “made this a political issue.”

Denial and shifting the blame, both time-honoured tactics of my former wayward students.

Next, the anger:

This morning's Star reports the following:

The federal New Democrats are hoping to put the Canada Revenue Agency under the microscope Tuesday after recalling a House of Commons committee to examine a wave of audits against registered charities.

NDP MP and revenue critic Murray Rankin (Victoria) has questioned whether the audits were politically motivated actions against those advocating for environmental causes and other issues clashing with the Harper government’s policies.

However, Revenue Minister Kerry-Lynne Findlay rejects the allegations, and with great umbrage:

“Your baseless allegation that I have used my office to blatantly misappropriate CRA resources to target and intimidate charities that don’t agree with our government’s policies is absolutely reprehensible,” wrote Findlay in a letter to Rankin, dated Aug. 5.

“As an honourable parliamentarian, I find your unwarranted attacks on the integrity of the CRA and my office shameful and plunges parliamentary discourses to new lows.”

To quote from my favourite Shakespearean play, "The lady doth protest too much, methinks." Such indignation may play well to the party's base, but critical thinkers may wonder at the rhetorical flourishes employed by Ms. Findlay here.

The final stage in the five stages of grief is acceptance. For the Harper regime, I suspect that will only come after the results of the next election.

A Debt Owed To The Media

As fashionable as it is to denigrate the mainstream media for their frequent timidity and conservatism, public knowledge about both Rob Ford's disgraceful performance as Mayor of Toronto and the current Senate scandal embroiling Stephen Harper, impeaching the integrity and honesty of both politicians, would not exist were it not for a diligent media, especially the press.

I have often stated in this blog that I am both proud and pleased to subscribe to The Toronto Star, given the integrity of its work and the fact that many of its investigations have resulted in change at both the local and the national level. These changes have included rigorous restaurant inspections whose results are now publicly posted to its most recent accomplishment, a promise from Minister of Health Rona Ambrose to remediate the situation after The Star brought to light the tragic death of Marit McKenzie, killed by a blood clot caused by an acne medication. At the time, Health Canada said that the drug safety review information was classified due to "confidential business information."

Yesterday, during an interview about her role in exposing the video apparently showing Rob Ford smoking crack, Star reporter Robin Doolittle encouraged people to take out a subscription to a newspaper, the implication being that the work they do is crucial in a democracy, and that work cannot be accomplished without the financial support of engaged readers.

Were it not for the diligent work of CTV reporter Robert Fife, who was instrumental in exposing Senategate, followed up by the efforts by other dedicated reporters, a corrupt and disdainful Prime Minister would be able to spin his tales of fancy without challenge. Instead, Stephen Harper and his cabal face what is likely their greatest crisis, one that may very well reverberate until the next election and could even result in criminal charges.

Watergate may have set the standard for investigative journalism, but the need for curious reporters with a passion for the truth will extend far into the future. No, whether we acknowledge it or not, a healthy press is a linchpin of a healthy democracy, augmented by social media and blogs, no doubt, but never to be replaced by them.

To reiterate Doolittle's message, "Get a newspaper subscription." The health of our political system may very well depend on you.

The Facade of Integrity – Harper Regime Calls in the RCMP

With an election in the air, the past few days have seen the Harper regime trying to perpetrate the illusion of integrity. On Tuesday we learned that Public Works Minister Rona Ambrose called in the RCMP to investigate allegations that Sebastian Togneri, a former staffer, tried to impede access to information requests by first trying to retract and then ordering heavy censoring of documents that had already been cleared for release. His subsequent resignation has allowed Ambrose to claim that “no current member of this government is involved in this case." Today we learn that former Conservative bigwig Bruce Carson is being investigated for influence-peddling. The investigation was ordered by Harper.

To the naive, the requests of Ambrose and Harper for police investigation might suggest an underlying integrity to the Harper Government. To many of us who follow Canadian politics, their actions bespeak a desperate attempt at damage control.

One need only look at the sequence of events in the Carson scandal. As reported in The Toronto Star,

“Carson reportedly illegally lobbied Indian Affairs Minister John Duncan on behalf of a company that was trying to sell water filtration systems to First Nations reserves with poor water quality. “

Federal law stipulates that no former employee of the government can engage in lobbying of that government for at least five years after leaving its employ.

I have a simple question for a Government that trumpets its empty rectitude: When he was being lobbied, why did Minister Duncan not report it and initiate action against Carson? Since Duncan had to have been well acquainted with both Carson and the lobbying regulations, why did he conceal his contacts with the former adviser?

My other question, which I think can readily be answered, is why has Harper called in the authorities at this point? The answer, I believe, is not difficult to deduce. As reported in The Star,

The Aboriginal Peoples Television Network uncovered the alleged wrongdoing in an investigation into the activities of Bruce Carson, a longtime Tory political operative who advised the Prime Minister on energy and environmental issues.

Since APTN is planning to broadcast a program on March 25 revealing the full details of its investigation, it would seem that Harper had no choice but to call in the authorities. In the letter (which APTN quoted) Harper's office sent to William Elliot, Commisioner of the RCMP:

a government official writes that Harper’s office “became aware of the existence of materials in the possession of the Aboriginal Peoples Television Network.”

“These materials contain troubling details about recent actions and claims made by Mr. Bruce Carson, a former employee of the Prime Minister’s Office,” wrote Ray Novak, Harper’s principal secretary.

The inference I draw from all of this is that because APTN is about to run this explosive expose, the Harper Government had no choice but to call in the RCMP in a desperate play at damage control and misdirection.

To attribute anything but the basest and most cynical motivation in this affair is to caught in the sleazy game the Prime Minister and his operatives play.